RTsafe and Elekta today announced that they have entered into a partnership agreement under which Elekta will provide RTsafe’s innovative 3D printed PseudoPatient™ phantoms combined with 3D remote dosimetry services, to its customers.

RTsafe announces that it has signed Abex Medical System as its exclusive distributor for Malaysia, Brunei, Vietnam, Myanmar, and Singapore.

The Forbes article discusses RTsafe's growth and how the company enhances the safety and efficiency in radiotherapy for brain cancer.

As part of the growing regional cooperation between Israel, Cyprus and Greece and acknowledging the great importance of cooperation in the field of innovation; high technology & entrepreneurship, RTsafe recently participated at a seminar in Israel.

Hygeia Hospital turned to RTsafe for its unique approach to quality assurance which significantly enhances the safety & efficiency of radiotherapy for cancer, especially when advanced radiotherapy applications, such as stereotactic radiosurgery, are used.

Join RTsafe at ASTRO 2018. Learn how we increase safety and efficiency in radiation oncology. Visit us at booth #2463.

New Personalized PseudoPatient™ promises increased patient safety: Radiation dosage and targeting can now be verified on ‘phantom patient’ before live treatment

RTsafe is in the process of establishing Lean Six Sigma methodologies aiming to achieve targeted improvements.

We'll be exhibiting at AAPM 2018, the world's largest program of scientific, educational and professional presentations and exhibits in the medical physics community. Meet RTsafe at booth # 337.

We’re proud to join the International Stereotactic Radiosurgery Society (ISRS) as a corporate member. We're looking forward to our collaboration in fostering learning and research on the topics of brain and body radiosurgery.